ATE373102T1 - Verbessertes in-vitro-synthesesystem - Google Patents

Verbessertes in-vitro-synthesesystem

Info

Publication number
ATE373102T1
ATE373102T1 AT02715053T AT02715053T ATE373102T1 AT E373102 T1 ATE373102 T1 AT E373102T1 AT 02715053 T AT02715053 T AT 02715053T AT 02715053 T AT02715053 T AT 02715053T AT E373102 T1 ATE373102 T1 AT E373102T1
Authority
AT
Austria
Prior art keywords
hydrolysis
vitro synthesis
improved
synthesis system
bonds
Prior art date
Application number
AT02715053T
Other languages
English (en)
Inventor
Deb Chatterjee
Mary Longo
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Application granted granted Critical
Publication of ATE373102T1 publication Critical patent/ATE373102T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Vibration Dampers (AREA)
AT02715053T 2001-03-08 2002-03-07 Verbessertes in-vitro-synthesesystem ATE373102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27382701P 2001-03-08 2001-03-08

Publications (1)

Publication Number Publication Date
ATE373102T1 true ATE373102T1 (de) 2007-09-15

Family

ID=23045560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02715053T ATE373102T1 (de) 2001-03-08 2002-03-07 Verbessertes in-vitro-synthesesystem

Country Status (8)

Country Link
US (1) US20020168706A1 (de)
EP (1) EP1373570B1 (de)
JP (1) JP4328530B2 (de)
AT (1) ATE373102T1 (de)
CA (1) CA2440531A1 (de)
DE (1) DE60222390T2 (de)
NZ (1) NZ528342A (de)
WO (1) WO2002072890A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119091A1 (en) * 2001-12-20 2003-06-26 Toru Ezure Cell-free protein synthesis method and extract solution therefor
US20040235029A1 (en) * 2003-04-28 2004-11-25 Lee Jae Moon In vitro translation system
KR20060019589A (ko) * 2003-06-10 2006-03-03 가부시키가이샤 시마즈세이사쿠쇼 포유동물 배양세포 추출액 및 그 조제방법, 및 상기추출액을 사용한 무세포계 단백질 합성방법
US20050136449A1 (en) * 2003-10-01 2005-06-23 Invitrogen Corporation Compositions and methods for synthesizing, purifying, and detecting biomolecules
JP4091901B2 (ja) * 2003-11-13 2008-05-28 株式会社島津製作所 無細胞系タンパク質合成におけるミクロソーム膜添加による翻訳後修飾方法
CN101014716B (zh) * 2003-11-20 2015-06-10 小利兰·斯坦福大学托管委员会 体外蛋白质合成的改进方法
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
US20080248565A1 (en) * 2007-03-01 2008-10-09 Invitrogen Corporation Isolated phospholipid-protein particles
EP2989202B1 (de) 2013-04-25 2019-04-10 Sutro Biopharma, Inc. Die verwendung des lambda-gam proteins in der ribosomen-display-technologie
BR112022002365A2 (pt) 2019-08-09 2022-04-26 Nutcracker Therapeutics Inc Métodos e aparelhos para fabricar e para remover material de uma composição terapêutica
CN117177818B (zh) 2021-02-25 2025-11-25 小麦生物科学有限责任公司 用于提取和分离纯化小麦胚产品的系统和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665563A (en) * 1991-10-11 1997-09-09 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
ES2097363T3 (es) * 1991-10-11 1997-04-01 Promega Corp Transcripcion y traduccion acopladas en un extracto exento de celulas eucariotas.
JP3434319B2 (ja) * 1993-06-15 2003-08-04 日本製粉株式会社 無細胞タンパク合成系によるタンパクの製造方法
US6168931B1 (en) * 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
JP4707237B2 (ja) * 1999-03-17 2011-06-22 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 外因性アミノ酸および新規atp再生システムを用いたインビトロ高分子生合成の方法
WO2001021830A1 (en) * 1999-09-24 2001-03-29 Ambion, Inc. Nuclease inhibitor cocktail

Also Published As

Publication number Publication date
JP4328530B2 (ja) 2009-09-09
EP1373570B1 (de) 2007-09-12
JP2004524847A (ja) 2004-08-19
US20020168706A1 (en) 2002-11-14
DE60222390T2 (de) 2008-06-19
WO2002072890A8 (en) 2003-03-13
NZ528342A (en) 2005-10-28
CA2440531A1 (en) 2002-09-19
EP1373570A1 (de) 2004-01-02
DE60222390D1 (de) 2007-10-25
WO2002072890A1 (en) 2002-09-19
EP1373570A4 (de) 2005-04-27

Similar Documents

Publication Publication Date Title
BR0010220A (pt) Compostos de pirimidinona
DK1117771T3 (da) Tørstofformige phytasesammensætninger
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
HN1999000083A (es) Compuestos de pirrolo(2,3-d) pirimidina
DE60222390D1 (de) Verbessertes in-vitro-synthesesystem
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
HUP9901640A2 (hu) Foszfolipáz aktivítású fehérje
AU2482800A (en) Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
PT1165558E (pt) Derivados de pirimido¬6,1-a|isoquinolina-4-ona
AU2003299585A8 (en) Water-soluble products and methods of making and using the same
EE9900105A (et) Bensonaftüridiinid bronhiaalravimitena
DE50008164D1 (de) Galactomannan-oligosaccharide und verfahren zu deren herstellung sowie deren verwendung
AU5630999A (en) Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
WO2003009104A3 (en) Business valuation system and method
ATE275956T1 (de) Veränderung der dns methyltransferase durch kombinationstherapie
ATE226588T1 (de) Phosphinsäure-derivate
WO2001087898A3 (de) N- (2-pyrimidinyl) (thio)phosphorsäuretriamide, verfahren zu ihrer herstellung, und deren verwendung als mittel zur regulierung bzw. hemmung der enzymatischen harnstoff-hydrolyse
PT1080104E (pt) Certos tiois heteroarilo substituidos inibidores da enzima conversora da endotelina
BG105003A (en) Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer
DE50110723D1 (de) Isolierte luziferasen sowie deren verwendung
WO2003087054A3 (en) Methods for identifying compounds that modulate enzymatic activity
AU2813200A (en) Assay for measuring different enzyme activities simultaneously
BR0114884A (pt) Compostos calcilìticos
AU2003245513A1 (en) Homogenous assay for enzymatic activity

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties